TherapeuticsMD Inc. logo

TherapeuticsMD Inc.

TXMD | NASDAQ
Chart Builder DCF Calculator
$2.10
-$0.09 (-4.11%)
At close: Sep 21, 2026, 4:00 PM ET
$2.10
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$24.31M
Enterprise Value
$20.68M
Beta
0.65
Average Volume
36.01K
Shares Outstanding (Diluted)
11.64K
Shares Change YoY
-99.9%
Institutional Ownership
33.96%
Exchange
NASDAQ
ISIN
US88338N2062

Price Performance

Price Change 1M
1.9%
Price Change 3M
5.0%
Price Change 6M
-8.3%
Price Change YTD
27.3%
Price Change 1Y
94.4%
Price Change 3Y
-30.2%
Price Change 5Y
-94.2%
1M CAGR (ann.)
1.4%
1Y CAGR (ann.)
94.4%
5Y CAGR (ann.)
-44.3%
All-Time CAGR
-32.4%

Valuation

PE Ratio
-94.59
Forward PE
11.06
PEG Ratio
-0.10
Forward PEG
-9.49
PS Ratio
7.43
Forward PS
2.60
PB Ratio
0.90
P/FCF Ratio
7.75
P/Adj. FCF Ratio
7.76
P/OCF Ratio
7.78
EV/Sales
6.32
EV/EBIT
-5.00
EV/EBITDA
-6.80
EV/FCF
6.59
Earnings Yield
-1.1%
FCF Yield
12.9%
Adj. FCF Yield
12.9%

Financial Health

Net Cash
$9.19M
Total Debt
$5.56M
Cash & Short-Term Investments
$9.19M
Total Assets
$37.53M
Current Ratio
3.22
Quick Ratio
3.22
Debt / Equity Ratio
0.20
Debt / EBITDA
-1.83
Debt / FCF
1.77
OCF / Debt
0.56
Interest Coverage
-963.00
Altman Z-Score
-34.04
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
89.9%
Operating Profit Margin
-118.2%
EBITDA Margin
-128.3%
Net Profit Margin
-6.6%
FCF Margin
95.9%
Adj. FCF Margin
95.8%
SBC / Revenue
0.0%
SBC Impact (per share)
-0.2%

Returns

Return on Assets
-0.6%
Return on Equity
-0.8%
Return on Invested Capital
-11.5%
Return on Capital Employed
-11.8%
Return on Tangible Assets
-0.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-47.8%
Revenue CAGR 5Y
-47.9%
Revenue CAGR 10Y
-16.6%
EPS CAGR 3Y
129.4%
EPS CAGR 5Y
70.4%
EPS CAGR 10Y
24.8%
FCF CAGR 3Y
-54.0%
FCF CAGR 5Y
-46.7%
FCF CAGR 10Y
29.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 16, 2026
EPS Estimate (next Q)
-$6.12
EPS Growth Est (next Q)
-46748.9%
Revenue Est (next Q)
$19.77M
Revenue Growth Est (next Q)
2421.4%

Cash Flow

Operating Cash Flow
$3.14M
Free Cash Flow
$3.14M
Adj. Free Cash Flow
$3.13M
FCF Per Share
$0.27
OCF Per Share
$0.27
OCF/S Ratio
95.4%

Income Statement

Revenue
$3.27M
Gross Profit
$2.95M
Operating Income
$-3.87M
EBITDA
$-3.04M
Net Income
$-217K
EPS (Diluted)
-$0.02
Revenue / Employee
$3.27M
Profit / Employee
$-217K
Employees
1

© 2026 bestshares.com. All rights reserved.